# Sources — Pierre Le Moyne d'Iberville

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 6, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Pothier B. "Le Moyne d'Iberville et d'Ardillières, Pierre." *Dictionary of Canadian Biography*, vol. 2 (University of Toronto/Université Laval, 1969; revised 1982). Baptized July 20, 1661, at Ville-Marie (Montreal), the third son of Charles Le Moyne de Longueuil et de Châteauguay and Catherine Thierry; the names d'Iberville (a fief of his father's family near Dieppe) and d'Ardillières (a property in Aunis near Rochefort); the Hudson Bay and James Bay campaigns from 1686 to 1697, with "25 died of scurvy and exposure" among the English on the Albany River and many deaths from scurvy on both sides at York Fort in 1694; Pemaquid (August 15, 1696) and the Newfoundland campaign (St John's, November 30); Fort Maurepas on Biloxi Bay, the fort on the Mississippi, and Fort Saint-Louis at Mobile; the cross of the order of Saint-Louis; the third voyage from La Rochelle on September 29, 1701, when "Forced by illness to put in at Pensacola"; "attacks of malaria which recurred several times from 1702 to 1705"; his "deteriorating health"; "well enough in 1705 to be entrusted with the preparation of an armament"; the capture of Nevis in 1706, where the whole population, including "6,000 negro slaves" (the source's words), was taken prisoner; and his death, "probably at Havana, Cuba, probably on 9 July 1706 of an unspecified illness," buried the same day in the church of San Cristóbal. The article records no wound to him. Three of his children were born at La Rochelle (1698, 1701, 1705). http://www.biographi.ca/en/bio/le_moyne_d_iberville_et_d_ardillieres_pierre_2E.html
2. Marsh JH. "Pierre Le Moyne d'Iberville et d'Ardillières." *The Canadian Encyclopedia* (Historica Canada; published January 21, 2008, last edited September 23, 2021). "baptised 20 July 1661 at Ville Marie"; the Pélican's battle near York Factory on September 5, 1697; the Newfoundland raids; the Louisiana forts; died probably July 9, 1706, at Havana, "likely of yellow fever." Graded **R** for the cause of death. https://www.thecanadianencyclopedia.ca/en/article/pierre-le-moyne-diberville-et-dardillieres
3. Pasquier MT. "Pierre Le Moyne d'Iberville." *64 Parishes* (Louisiana Endowment for the Humanities). Born July 16, 1661, in Montreal; chose the site of Fort Maurepas, near present-day Ocean Springs, Mississippi, on April 8, 1699; "a merciless and lucrative expedition against British posts throughout Newfoundland"; missed the 1703 expedition "due to illness"; died July 9, 1706, in Havana of yellow fever; "The site of his burial is unknown." Graded **R** for the cause of death. https://64parishes.org/entry/pierre-le-moyne-diberville-2
4. HISTMED Master Roster v3. Internal project source. Its clinical claims (yellow fever, scurvy, combat wounds, environmental exposure, the stress of command, alcohol in expedition journals) were provisional and were not treated as independent corroboration.

## Clinical guidance

1. Centers for Disease Control and Prevention. "Treatment of Uncomplicated Malaria" (clinical guidance, reviewed August 17, 2026). Chloroquine for P. vivax acquired outside Papua New Guinea and Indonesia; "CDC recommends a daily dose of 30 mg (base) of primaquine phosphate by mouth for 14 days for adults," with a total of 6 mg/kg for patients of 70 kg or more; quantitative G6PD testing before primaquine or tafenoquine; a negative smear ideally documented within one week of finishing treatment. https://www.cdc.gov/malaria/hcp/clinical-guidance/treatment-of-uncomplicated-malaria.html
2. CDC Yellow Book: Health Information for International Travel, 2026 edition. "Malaria" (atovaquone-proguanil from 1 to 2 days before to 7 days after the endemic area; primaquine terminal prophylaxis, 30 mg base daily for 14 days, after prolonged P. vivax exposure, with G6PD ruled out by a quantitative test; standby treatment; mosquito avoidance), https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/malaria.html; "Yellow Fever" ("a single dose of YF vaccine provides long-lasting protection"; contraindications and precautions, including age 60 or older; the certificate is valid from 10 days after vaccination), https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/yellow-fever.html; "Dengue" ("There are currently no dengue vaccines recommended for travelers in the United States"), https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/dengue.html; "Rickettsial Diseases" (typhus; repellents; doxycycline as the treatment of choice), https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/rickettsial-diseases.html; "Travelers' Diarrhea" (azithromycin preferred for severe diarrhea), https://www.cdc.gov/yellow-book/hcp/preparing-international-travelers/travelers-diarrhea.html
3. Centers for Disease Control and Prevention. French Guiana (France) destination page (yellow fever and malaria sections updated April 23, 2025): yellow fever vaccine "required for all arriving travelers ≥1 year old" and recommended for all travelers 9 months or older; hepatitis A and hepatitis B for unvaccinated travelers; typhoid for some travelers; rabies in bats; a chikungunya outbreak with vaccination recommended; malaria mainly near the Brazil and Suriname borders and in Kourou, Matoury and Saint-Élie, mostly P. vivax, with chloroquine resistance; atovaquone-proguanil, doxycycline, mefloquine or tafenoquine. https://wwwnc.cdc.gov/travel/destinations/traveler/none/french-guiana
4. Hill DR, et al. "The practice of travel medicine: guidelines by the Infectious Diseases Society of America." *Clin Infect Dis* 2006;43(12):1499–1539. PMID 17109284. https://pubmed.ncbi.nlm.nih.gov/17109284/
5. Stevens DL, et al. "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America." *Clin Infect Dis* 2014;59(2):e10–e52. PMID 24973422. Used for the sick visit (incision and drainage for a simple abscess). https://pubmed.ncbi.nlm.nih.gov/24973422/
6. Preventive visit: Medicare Preventive Services reference (Aether Forge, 2026), https://patrickrutledge.github.io/preventative_services/; USPSTF A and B recommendations, depression (2023), unhealthy alcohol use (2018), colorectal cancer (2021), HIV (2019) and hepatitis C (2020) screening; CDC hepatitis B screening (2023, PMID 36893044); CDC adult immunization schedule by age.

## Editorial resolutions

- **Index age and whereabouts.** The modern episode presents him at 43. The synthetic date of birth is 1982-07-16 (the true month and day of birth), so the shift is 321 years. The index visit is February 17, 2026 (true frame February 17, 1705) and the last visit is October 13, 2026 (true frame October 13, 1705). His biographer places him in France in these years, between attacks of malaria, and says he was entrusted in 1705 with preparing the armament with which he sailed early in 1706; one of his children was born at La Rochelle in 1705. His day-to-day whereabouts in 1705 were not verified. The period was chosen because it is the documented interval of recurrent illness just before a tropical campaign, which is the brief's teaching point. He turns 44 in the true frame on July 16, 1705, so the last two visits describe him as 44.
- **Birth date.** The Dictionary of Canadian Biography and the Canadian Encyclopedia give only the baptism, July 20, 1661; 64 Parishes gives the birth on July 16, 1661. The birth date is preferred and the baptism recorded as a conflicting alternative. France and New France used the Gregorian calendar, so no conversion is needed.
- **Name.** `identity.name_parts` gives "Pierre" as the given name and "Le Moyne d'Iberville" as the family name, written as the display name and as the Dictionary of Canadian Biography headword, so that the family name carried in C-CDA and FHIR keeps the form by which he is known. Strictly, Le Moyne is the family name and d'Iberville a territorial designation from a fief of his father's family near Dieppe; recording "Le Moyne" alone would lose the name used everywhere else. The aliases are the full form "Pierre Le Moyne d'Iberville et d'Ardillières" and "Sieur d'Iberville"; neither appears in another record. The apostrophe is kept exactly. The modern notes call him "Mr. Le Moyne d'Iberville."
- **Cause of death.** The Dictionary of Canadian Biography says "an unspecified illness"; the Canadian Encyclopedia says "likely of yellow fever" and 64 Parishes says yellow fever. The yellow fever attribution is graded **R**, disputed. No fetched source names typhus, so typhus as a cause is not recorded. The death is after the episode and is not used in it; the modern travel plan makes no prediction.
- **The brief's abscess.** No fetched source mentions an abscess around 1701 to 1702. The documented illness of that time is an unnamed illness that forced him into Pensacola in 1701 and attacks his biographer calls malaria from 1702 to 1705; those are recorded instead. The modern sick visit for a skin abscess is synthetic and is not a claim about his health.
- **Thin chart.** His documented health history is thin: an unnamed illness at sea in 1701, recurrent attacks called malaria from 1702 to 1705, and declining health, followed by a sudden death in Havana. Nothing else about his own health was found. The modern episode is built around a defensible modern counterpart of the documented recurrent fevers, relapsing Plasmodium vivax malaria after blood-stage treatment alone, followed by pre-travel care. The species, the PCR result and every test are synthetic; no source says what infection he had, and malaria is his biographer's word.
- **Roster leads.** The roster's "scurvy" is supported only as an illness of the men in his campaigns, not of Iberville himself (CLM-0004). The roster's "multiple combat wounds" and "alcohol in expedition journals" were not found in any fetched source, and the Dictionary of Canadian Biography records no wound to him; they are not recorded as claims and are not used. The roster's "yellow fever (fatal)" is recorded as the disputed attribution above.
- **Destination.** His 1706 campaign went to Martinique, Nevis and Havana. Today none of those islands needs yellow fever vaccine, so the modern deployment adds French Guiana, a French territory where yellow fever vaccination is required for entry and malaria (mostly P. vivax) is transmitted. This is a synthetic choice that lets the episode teach the brief's yellow fever vaccination and malaria chemoprophylaxis.
- **Choice of treatment.** Chloroquine is used for the blood stage because the modern infections are placed on the Caribbean coast of Central America, where P. vivax is chloroquine-sensitive; primaquine rather than tafenoquine is used for radical cure because it is the CDC's standard 14-day regimen. His synthetic weight is under 70 kg, so the 14-day course gives the full recommended dose. Atovaquone-proguanil is chosen for prophylaxis in French Guiana because chloroquine resistance is noted there and it is stopped seven days after the malaria areas; primaquine terminal prophylaxis follows because of months of P. vivax exposure. Rabies pre-exposure vaccination was discussed and he declined it, a choice consistent with shipboard and coastal duties. The chikungunya vaccine decision is left open at the last visit, against the CDC outbreak notice then current, because the notice may change before departure. Height, weight and all results are synthetic.
- **No CMID monograph.** The CMID does not cover malaria or travel medicine, so the focused visits follow the CDC treatment guidance, the CDC Yellow Book 2026 and the IDSA travel medicine guideline, as the brief allows.
- **Enslaved people and captives.** The capture of Nevis, with about 6,000 enslaved Africans seized, and the roughly 700 prisoners taken in Newfoundland are recorded plainly as documented history. No health fact about any of them is recorded, and none of them appears in the modern episode. Whether he himself held enslaved people was not checked in a fetched source and is not recorded.
- **Family and other people.** His parents are named in the birth claim only. No family medical history is recorded, and his wife, children and brothers are not named in the modern episode; no health fact is given about any of them. His brothers' deaths in combat are left out as other people's history.
- **Habits.** "Never smoked" and about eight drinks of wine a week are synthetic and not claims about his real habits.
- **Sick and preventive visits.** A periodic adult preventive visit (age 43) on April 21, 2026 (true frame April 21, 1705) and a same-day sick visit on June 9, 2026 (true frame June 9, 1705) were added. The sick visit is a small skin abscess of the forearm from a dockyard splinter, managed by incision and drainage alone under the IDSA guideline; it teaches that an afebrile abscess needs no malaria test while any fever would. The culture result (methicillin-susceptible Staphylococcus aureus) is reported in the next note.
- **Focused visits.** The four chronic-care follow-ups (two weeks, six weeks, the pre-travel visit at about five months, and the pre-departure visit at about eight months) are documented as focused visits on the CDC malaria treatment guidance (G6PD, radical cure, blood count, follow-up smear, relapse surveillance) and the CDC Yellow Book 2026 and IDSA pre-travel care. One protocol deviation is recorded: the smear and PCR meant for one week after the last primaquine dose were not drawn because no date was booked; they were drawn two weeks after finishing, both negative, with no harm and a corrective action. The PCR, smear, G6PD and serology results that have no numeric value are given in the notes only.
- **Consultation.** The infectious diseases (travel medicine) consultation by the fictional Dr. Okonkwo-Hale on the second visit is synthetic. Its recommendations (chloroquine and primaquine, the post-treatment tests, the travel vaccines with the certificate, atovaquone-proguanil with primaquine terminal prophylaxis, vector and food and water precautions with standby azithromycin) are those the later visits carry out.
- Iberville died in 1706, so the recent-death review rule does not apply. Ordinary clinical and provenance reviews remain required.
